In-Hospital and 1-Year Mortality Associated with Diabetes in Patients with Acute Heart Failure: Results from the ESC-HFA Heart Failure Long-Term Registry
Giovanni Targher(Ospedale Sacro Cuore Don Calabria), S.D. Anker, María G. Crespo‐Leiro(Complexo Hospitalario Universitario A Coruña), Gerasimos Filippatos(National and Kapodistrian University of Athens), Luigi Tavazzi(Maria Cecilia Hospital), Jarosław Dróżdż(Copenhagen University Hospital), Andrew J.S. Coats(The Heart Research Institute), Marco Dauriz(Ospedale di Bolzano), Pier Luigi Temporelli(Fondazione Salvatore Maugeri), Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Massimo Piepoli(University of Milan), Aldo P. Maggioni(Health Care Foundation), Roberto Ferrari(University of Ferrara), Mahmoud Hassanein(Alexandria University), Cécile Laroche(European Society of Cardiology)
Cited by 171
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k